This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lutchman, M. Articles by Rouleau, G. A. Search for Related Content PubMed PubMed Citation Articles by Lutchman, M. Articles by Rouleau, G. A.

The Neurofibromatosis Type 2 Gene Product, Schwannomin, Suppresses Growth of NIH 3T3 Cells¹

Centre for Research in Neurosciences, McGill University and the Montreal General Hospital, Montreal, Quebec H3G 1A4, Canada

Cancer is a multistep process that involves the activation of oncogenes and the inactivation of antioncogenes. Recently, a new putative tumor suppressor, the neurofibromatosis type 2 (NF2) gene, was mapped to chromosome 22, cloned, and found to encode for a new protein, merlin/schwannomin, a member of the band 4.1 family of proteins. Members of this family have not been implicated previously in tumorigenesis. They possess significant homology in their NH₂-terminal domain, which is thought to be important in the binding of the plasma membrane to the underlying actin cytoskeleton. To determine whether schwannomin may affect cell growth, we transfected NIH 3T3 cells with the wild type and an NF2 cDNA lacking 111 amino acids at the NH₂ terminus. We observed slowing of growth and changes in cellular morphology only in cells expressing the wild-type NF2 cDNA. This finding suggests that schwannomin can suppress growth directly and confirms its role in tumor suppression. This system will provide a useful assay to identify important functional domains of the protein.

¹ G. A. R. is funded by the Medical Research Council (Montreal, Quebec, Canada) and the Fonds de Recherche en Santé du Québec.

² To whom requests for reprints should be addressed, at Montreal General Hospital, Room L7-224, 1650 Cedar Avenue, Montreal, Quebec H3G 1A4, Canada.

Received 2/15/95. Accepted 4/20/95.

This article has been cited by other articles:

				T. Muranen, M. Gronholm, A. Lampin, D. Lallemand, F. Zhao, M. Giovannini, and O. Carpen The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton Hum. Mol. Genet., July 15, 2007; 16(14): 1742 - 1751. [Abstract] [Full Text] [PDF]

				H. Lee, D. Kim, H. C. Dan, E. L. Wu, T. M. Gritsko, C. Cao, S. V. Nicosia, E. A. Golemis, W. Liu, D. Coppola, et al. Identification and Characterization of Putative Tumor Suppressor NGB, a GTP-Binding Protein That Interacts with the Neurofibromatosis 2 Protein Mol. Cell. Biol., March 15, 2007; 27(6): 2103 - 2119. [Abstract] [Full Text] [PDF]

				D. R. Scoles, W. H. Yong, Y. Qin, K. Wawrowsky, and S. M. Pulst Schwannomin inhibits tumorigenesis through direct interaction with the eukaryotic initiation factor subunit c (eIF3c) Hum. Mol. Genet., April 1, 2006; 15(7): 1059 - 1070. [Abstract] [Full Text] [PDF]

				A. I. McClatchey and M. Giovannini Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin Genes & Dev., October 1, 2005; 19(19): 2265 - 2277. [Abstract] [Full Text] [PDF]

				G.-H. Xiao, R. Gallagher, J. Shetler, K. Skele, D. A. Altomare, R. G. Pestell, S. Jhanwar, and J. R. Testa The NF2 Tumor Suppressor Gene Product, Merlin, Inhibits Cell Proliferation and Cell Cycle Progression by Repressing Cyclin D1 Expression Mol. Cell. Biol., March 15, 2005; 25(6): 2384 - 2394. [Abstract] [Full Text] [PDF]

				K. M. M. Schulze, C. O. Hanemann, H. W. Muller, and H. Hanenberg Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis Hum. Mol. Genet., January 1, 2002; 11(1): 69 - 76. [Abstract] [Full Text] [PDF]

				D. H. Gutmann, A. C. Hirbe, and C. A. Haipek Functional analysis of neurofibromatosis 2 (NF2) missense mutations Hum. Mol. Genet., July 1, 2001; 10(14): 1519 - 1529. [Abstract] [Full Text] [PDF]

				D. H. Gutmann, C. A. Haipek, S. P. Burke, C.-X. Sun, D. R. Scoles, and S. M. Pulst The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the 'open' conformation and suppresses cell growth and motility Hum. Mol. Genet., April 1, 2001; 10(8): 825 - 834. [Abstract] [Full Text] [PDF]

				M. Sainio, J. Jaaskelainen, H. Pihlaja, and O. Carpen Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus Neurology, March 14, 2000; 54(5): 1132 - 1138. [Abstract] [Full Text] [PDF]

				L. Goutebroze, E. Brault, C. Muchardt, J. Camonis, and G. Thomas Cloning and Characterization of SCHIP-1, a Novel Protein Interacting Specifically with Spliced Isoforms and Naturally Occurring Mutant NF2 Proteins Mol. Cell. Biol., March 1, 2000; 20(5): 1699 - 1712. [Abstract] [Full Text]

				M Gronholm, M Sainio, F Zhao, L Heiska, A Vaheri, and O Carpen Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin J. Cell Sci., January 3, 1999; 112(6): 895 - 904. [Abstract] [PDF]

				Y. K. Tran, O. Bogler, K. M. Gorse, I. Wieland, M. R. Green, and I. F. Newsham A Novel Member of the NF2/ERM/4.1 Superfamily with Growth Suppressing Properties in Lung Cancer Cancer Res., January 1, 1999; 59(1): 35 - 43. [Abstract] [Full Text] [PDF]

				A. I. McClatchey, I. Saotome, K. Mercer, D. Crowley, J. F. Gusella, R. T. Bronson, and T. Jacks Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors Genes & Dev., April 15, 1998; 12(8): 1121 - 1133. [Abstract] [Full Text]

				V. F. Mautner, M. Lindenau, M. E. Baser, L. Kluwe, and J. Gottschalk Skin Abnormalities in Neurofibromatosis 2 Arch Dermatol, December 1, 1997; 133(12): 1539 - 1543. [Abstract] [PDF]

				M Sainio, F Zhao, L Heiska, O Turunen, M den Bakker, E Zwarthoff, M Lutchman, G. Rouleau, J Jaaskelainen, A Vaheri, et al. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton J. Cell Sci., January 9, 1997; 110(18): 2249 - 2260. [Abstract] [PDF]

				M. Jannatipour, P. Dion, S. Khan, H. Jindal, X. Fan, J. Laganiere, A. H. Chishti, and G. A. Rouleau Schwannomin Isoform-1 Interacts with Syntenin via PDZ Domains J. Biol. Chem., August 24, 2001; 276(35): 33093 - 33100. [Abstract] [Full Text] [PDF]